Zobrazeno 1 - 10
of 88
pro vyhledávání: '"Déborah Hirt"'
Autor:
Manon Tauzin, Béatrice Gouyon, Déborah Hirt, Ricardo Carbajal, Jean-Bernard Gouyon, Anne-Claire Brunet, Matthieu Ortala, Seydou Goro, Camille Jung, Xavier Durrmeyer
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Objectives: No consensus exists about the doses of analgesics, sedatives, anesthetics, and paralytics used in critically ill neonates. Large-scale, detailed pharmacoepidemiologic studies of prescription practices are a prerequisite to future research
Externí odkaz:
https://doaj.org/article/9bc3bb945d854937a7fe0026998d353d
Autor:
Charlotte Collignon, Charles de Marcellus, Mehdi Oualha, Valentin Neuranter, Claire Heilbronner, Déborah Hirt
Publikováno v:
Pediatric Nephrology.
Autor:
Agathe Debray, Delphine Callot, Déborah Hirt, Emmanuelle Bille, Sylvain Renolleau, Laurent Chouchana, Jean-Marc Tréluyer, Mehdi Oualha, Agathe Béranger
Publikováno v:
European Journal of Pediatrics. 182:975-976
Autor:
Julie Toubiana, Jean-Marc Tréluyer, Sihem Benaboud, E. Bille, Saik Urien, Florence Moulin, Guillaume Geslain, Mehdi Oualha, E. Salvador, Yi Zheng, Inès Gana, C. Briand, Olivier Bustarret, Déborah Hirt, S. Renolleau, S. Boujaafar, Agathe Béranger
Publikováno v:
Clinical Microbiology and Infection. 27:413-419
Objectives Cefazolin is one of curative treatments for infections due to methicillin-sensitive Staphylococcus aureus (MSSA). Both growth and critical illness may impact the pharmacokinetic (PK) parameters. We aimed to build a population PK model for
Autor:
Radia Aboura, Naïm Bouazza, Inès Gana, Jean-Marc Tréluyer, Isabelle Desguerre, Camille Chenevier-Gobeaux, Yi Zheng, Rima Nabbout, Déborah Hirt, Manon Tauzin, Sihem Benaboud, Cécile Freihuber, Thierry Billette de Villemeur
Publikováno v:
The Journal of Clinical Pharmacology. 61:677-687
Lamotrigine is a broad-spectrum antiepileptic drug with high interindividual variability in serum concentrations in children. The aims of this study were to evaluate the predictive performance of pediatric population pharmacokinetic (PPK) models publ
Autor:
Saik Urien, Caroline Yonaba, Jean-Marc Tréluyer, Alain Pruvost, Sophie Desmonde, Désiré Lucien Dahourou, Frantz Foissac, Evelyne Dainguy, Karen Malateste, Claire Pressiat, Déborah Hirt, Valériane Leroy, Naïm Bouazza, François Tanoh Eboua
Publikováno v:
Antiviral therapy. 26(6-8)
Background Few pharmacokinetic data were reported on dispersible tablets despite their increasing use. One hundred fifty HIV-infected children receiving lamivudine were enrolled in the MONOD ANRS 12,206 trial. Three galenic forms were administered: l
Autor:
Frantz Foissac, Yves Ville, Patrick Rozenberg, Sihem Benaboud, Déborah Hirt, Yi Zheng, Gabrielle Lui, Laurent Mandelbrot, Naïm Bouazza, Jean-Marc Tréluyer, Pierre-Henri Jarreau, Gilles Kayem, François Goffinet
Publikováno v:
Clinical Pharmacology and Therapeutics
Clinical Pharmacology and Therapeutics, American Society for Clinical Pharmacology and Therapeutics, 2020, 108 (5), pp.1026-1035. ⟨10.1002/cpt.1887⟩
Clinical Pharmacology and Therapeutics, American Society for Clinical Pharmacology and Therapeutics, 2020, 108 (5), pp.1026-1035. ⟨10.1002/cpt.1887⟩
International audience; Despite antenatal corticosteroids therapy, respiratory distress syndrome (RDS) is still a leading cause of neonatal morbidity and mortality in premature newborns. To date, the relationship between in utero fetal drug exposure
Autor:
Noémie de Cacqueray, Déborah Hirt, Yi Zheng, Emmanuelle Bille, Pierre Louis Leger, Jérôme Rambaud, Julie Toubiana, Anais Chosidow, Sophie Vimont, Delphine Callot, Laurent Chouchana, Agathe Béranger, Jean Marc Tréluyer, Sihem Benaboud, Mehdi Oualha
Publikováno v:
Clinical Microbiology and Infection. 28:1389.e1-1389.e7
Cefepime is commonly used in pediatric intensive care units, where unpredictable variations in the patients' pharmacokinetic (PK) variables may require drug dose adjustments. The objectives of the present study were to build a population PK model for
Autor:
Elsa Salomon, Déborah Hirt, Benjamin Davido, Jean-Claude Alvarez, Hugues Michelon, Aurélien Dinh, Jean-Laurent Le Quintrec, Marie Tardivel
Publikováno v:
Fundamental & Clinical Pharmacology. 34:521-524
Ceftazidime is a third-generation cephalosporin used for the treatment of Gram-negative bacteria only approved for parenteral use by intravenous and intramuscular route. In some clinical situations, off-label subcutaneous injection could be a salvage
Autor:
Mehdi Oualha, Naïm Bouazza, Sihem Benaboud, Frantz Foissac, Florence Moulin, Jean-Marc Tréluyer, Emmanuelle Bille, Inès Gana, Sylvain Renolleau, Agathe Béranger, Saik Urien, Yi Zheng, Fabrice Lesage, Déborah Hirt, Mélanie Rapp
Publikováno v:
European Journal of Clinical Pharmacology. 76:61-71
We aimed to develop a meropenem population pharmacokinetic (PK) model in critically ill children and simulate dosing regimens in order to optimize patient exposure. Meropenem plasma concentration was quantified by high-performance liquid chromatograp